These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37533489)
1. Bilateral localized bullous pemphigoid in a young adult patient: A case report. Nourmohammadpour P; Akhdar M; Ghanadan A; Peymanfar AA; Saberi F; Keshavarz-Fathi M SAGE Open Med Case Rep; 2023; 11():2050313X231190730. PubMed ID: 37533489 [TBL] [Abstract][Full Text] [Related]
2. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299 [TBL] [Abstract][Full Text] [Related]
3. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum. Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183 [TBL] [Abstract][Full Text] [Related]
4. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid? Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339 [TBL] [Abstract][Full Text] [Related]
6. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979 [TBL] [Abstract][Full Text] [Related]
8. Annular bullous pemphigoid: A case report and review of literature. Arès S; Lim D; Jung S; Bouffard D; Mereniuk A SAGE Open Med Case Rep; 2022; 10():2050313X221093128. PubMed ID: 35495292 [TBL] [Abstract][Full Text] [Related]
9. PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides. Özkesici B; Koç S; Akman-Karakaş A; Yılmaz E; Başsorgun İC; Uzun S Case Rep Dermatol Med; 2017; 2017():6134752. PubMed ID: 28567313 [No Abstract] [Full Text] [Related]
10. Localized bullous pemphigoid recurring at different sites: two case reports. Hasegawa A; Shinkuma S; Katsumi T; Kasahara N; Ito K; Ujiie H; Ishii N; Hashimoto T; Abe R Eur J Dermatol; 2020 Feb; ():. PubMed ID: 32031525 [TBL] [Abstract][Full Text] [Related]
11. Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study. Sernicola A; Russo I; Saponeri A; Alaibac M Medicine (Baltimore); 2019 Feb; 98(7):e14514. PubMed ID: 30762788 [TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report. Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600 [TBL] [Abstract][Full Text] [Related]
13. Drug-aggravated Bullous Pemphigoid in a 47-year-old Asian Woman - A Case Report. Nelramachandrakumar D; Hariharan H; Nagamanickam S; Chander J SJU Curr Drug Saf; 2023; 18(3):379-382. PubMed ID: 35593331 [TBL] [Abstract][Full Text] [Related]
14. IgA bullous pemphigoid: a distinct blistering disorder. Case report and review of the literature. Jones RR; Goolamali SK Br J Dermatol; 1980 Jun; 102(6):719-25. PubMed ID: 7000138 [TBL] [Abstract][Full Text] [Related]
15. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Atzori L; Deidda S; Aste N G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046 [TBL] [Abstract][Full Text] [Related]